Breast milk alone is the optimal source of nutrition for newborns for the first 6 months after birth [ 1 ]. Compared to formula, both breastfeeding and donor human milk (DHM) have immense advantages, as they are associated with reduced rates of …
verfasst von:
Hu Xiaoshan, Chu Xue, Zhang Jun, Liu Feng, Chen Xiaohui, Yu Zhangbin, Han Shuping
On 11 March 2020, the World Health Organization (WHO) declared the outbreak of Coronavirus disease 2019 (COVID-19) as a public health emergency of international concern [ 1 , 2 ]. The number of infected cases and deaths due to COVID-19 is rising …
Acute kidney injury (AKI) is independently associated with increased mortality in hospitalized patients with corona virus disease 19 (COVID-19) and may result in higher odds of death than AKI due to other causes [ 1 ]. AKI also increases the risk …
verfasst von:
Tomas Luther, Per Eckerbom, Eleanor Cox, Miklos Lipcsey, Sara Bülow, Michael Hultström, Francisco Martinez Torrente, Jan Weis, Fredrik Palm, Susan Francis, Robert Frithiof, Per Liss
Malaria remains a serious threat to development in intertropical countries, in spite of a reduction in malaria cases estimated to 229 million cases in 2019 from 238 million in 2000. The Democratic Republic of the Congo (DRC) is the second most …
verfasst von:
Joris Losimba Likwela, Phillipe Lukanu Ngwala, Albert Kalonji Ntumba, Deogratias Cibinda Ntale, Eric Mukomena Sompwe, Godé Kanyeba Mpiana, Joseph Kalonji Tshula, Tathy Kalonda Likwela, Patrick Kanku-Ka-Munabe, Adrien N.’siala Kumbi, Gilbert Kulimushi Ndahambara, Helen Cibinda Ntale, Michele Luntadila Kiamenga, Jules Kabongo Njila, Ghislain Makhan Yav, Didier Gasigwa Baneti, Julian Austin
The Pfizer-BioNTech (BNT162b2) mRNA vaccine (Pfizer vaccine) against COVID-19 was granted emergency use authorization (EUA) by the Food and Drug Administration (FDA) in December 2020 [ 1 ]. There is very limited data in the literature about the …
verfasst von:
Rajib Kumar Dey, Hemamala Ilango, Subash Bhatta, Ahmed Shaheed, Shanaz Dole, Ahmed Zooshan, Mohamed Faisham, Moosa Murad
Recruitment to clinical trials is challenging under normal circumstances, and understanding patient and public attitudes to clinical research is critical for trial design. Previous studies have found that motivating factors for trial participation …
verfasst von:
Dalia Abdulhussein, Timothy E. Yap, Haider Manzar, Serge Miodragovic, Francesca Cordeiro
The frequency and scale of Emerging Infectious Diseases (EIDs) with pandemic potential has been increasing over the last two decades and, as COVID-19 has shown, such zoonotic spill-over events are an increasing threat to public health globally.
As of June 2021, the novel coronavirus disease (COVID-19) pandemic has claimed the lives of over 590,000 individuals in the US and 3.8 million globally [ 1 ]. Public health experts suggest that the intersection of the COVID-19 pandemic and the …
verfasst von:
Abeed Sarker, Nisha Nataraj, Wesley Siu, Sabrina Li, Christopher M. Jones, Steven A. Sumner
In 2020, the World Health Organisation (WHO) declared the novel 2019-nCoV (coronavirus disease 2019) a global pandemic [ 1 – 3 ]. In response, countries have taken drastic actions to curb the rate of COVID-19 infections including implementing rapid …
verfasst von:
Nadine Harker, Kim Johnson, Jodilee Erasmus, Bronwyn Myers
Spain has been hit hard by the SARS-CoV-2 pandemic, experiencing the largest drop in life expectancy in 2020 in the whole of Europe: 1.6 years [ 1 ]. In the first wave, metropolitan areas like Madrid and Barcelona registered very high rates of …
verfasst von:
Davide Malmusi, M. Isabel Pasarín, Marc Marí-Dell’Olmo, Lucía Artazcoz, Elia Diez, Sara Tolosa, Maica Rodríguez-Sanz, Glòria Pérez, Conchita Peña-Gallardo, Carme Borrell
The world has grappled with COVID-19 since the first case was diagnosed in Wuhan, China [ 1 ]. This has resulted in a global socio-economic crisis and challenged healthcare systems throughout the world. Healthcare workers (HCWs) are at constant …
verfasst von:
Adeel Abid, Hania Shahzad, Hyder Ali Khan, Suneel Piryani, Areeba Raza Khan, Fauziah Rabbani
Multiple international efforts have been working at an unprecedented pace to make the coronavirus disease 2019 (caused by the severe acute respiratory syndrome coronavirus 2 SARS-CoV-2), a vaccine-preventable disease. Success of immunization …
The spectrum of clinical manifestations and differential diagnosis associated with coronavirus disease 2019 (COVID-19) is broad, ranging from fever and cutaneous eruptions to respiratory distress or even neurological disorders. Coinfections and …
verfasst von:
Jowita Bruno, Silvio Ragozzino, Jonas Quitt, Martin Siegemund, Niklaus Labhardt
The coronavirus disease 2019 (COVID-19) pandemic has resulted in a growing population of individuals who experience a wide range of long-lasting symptoms after recovery from the acute illness, referred to by several terms, including “post-COVID …
Coronavirus disease 2019 (COVID-19), an infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was initially not attributed to serious maternal or neonatal morbidities [ 1 , 2 ]. However, with the evolving literature, it …
verfasst von:
Pradip Kalsar, Shreya Datta, Arbabasu Kalsar, Andrew Marvin Kanyike
The World Health Organization (WHO) declared COVID-19 to be a public health emergency of international concern [ 1 ]. As of October 2020, COVID-19 had infected more than 37 million people worldwide, with more than a million deaths reported to the …
verfasst von:
Abdulkarim Yousef Aldehaim, Abrar Mohammed Alfaifi, Seham Nehdal Hussain, Abdulaziz Mohammed Alrajhi
A new coronavirus, the severe acute respiratory distress syndrome–coronavirus-2 (SARS-CoV-2/ COVID-19), has spread fast throughout the world, leading to high morbidity and mortality [ 1 ]. COVID-19 is chiefly a respiratory infection, and the …
Strengthening pandemic preparedness systems is central to reduce the impact of pandemics on vital societal functions [ 28 ]. In many countries the COVID-19 pandemic has unsettled belief in the ability of existing preparedness principles and …
On 11 December 2020, the Food and Drug Administration issued an emergency use authorization for the Pfizer–BioNTech vaccine to prevent COVID-19, administered as two doses separated by 21 days.
verfasst von:
José Manuel Ortiz-Egea, Cristina Gómez Sánchez, Andrés López-Jiménez, Olga Diego Navarro
The COVID-19 pandemic has put health systems worldwide under pressure and tested their resilience. The World Health Organization (WHO) acknowledges health workforce as one of the six building blocks of health systems [ 1 ]. Health care workers …
verfasst von:
Souaad Chemali, Almudena Mari-Sáez, Charbel El Bcheraoui, Heide Weishaar